食管癌市场和流行病学洞察2023-2032年:潜在药物Zanidatamab、Sintilimab、Tislelizumab和Sotigalimab预计将对市场产生重大影响

13 6 Esophageal Cancer Market and Epidemiology Insights 2023-2032: Potential Drugs Zanidatamab, Sintilimab, Tislelizumab, and Sotigalimab Expected to Significantly Impact the Market

DUBLIN, Aug. 17, 2023 – “食管癌 – 2032年市场洞察、流行病学和市场预测” 报告已添加到ResearchAndMarkets.com的提供中。2022年,食管癌(EC)市场经历了巨大增长,美国拥有约4亿美元的最大市场规模。到2032年,它预计将进一步增加。… 继续阅读 “Esophageal Cancer Market and Epidemiology Insights 2023-2032: Potential Drugs Zanidatamab, Sintilimab, Tislelizumab, and Sotigalimab Expected to Significantly Impact the Market”